This International Standard specifies a PROCESS for a MANUFACTURER to analyse, specify, design, VERIFY and VALIDATE USABILITY, as it relates to SAFETY of a MEDICAL DEVICE. This USABILITY ENGINEERING PROCESS assesses and mitigates RISKS caused by USABILITY problems associated with CORRECT USE and USE ERRORS. It can be used to identify but does not assess or mitigate RISKS associated with ABNORMAL USE. If the USABILITY ENGINEERING PROCESS detailed in this International Standard has been complied with and the acceptance criteria established in the USABILITY VALIDATION plan have been met (see 29 5.7), then the RESIDUAL RISKS, as defined in ISO 14971, associated with USABILITY of a MEDICAL DEVICE are presumed to be acceptable, unless there is OBJECTIVE EVIDENCE to the contrary. This International Standard does not apply to clinical decision-making relating to the use of a MEDICAL DEVICE.

Customers who purchased DS DS/EN 62366
also purchased

• AENOR UNE-EN ISO 10993-1/AC : Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process - Technical Corrigendum 1 (ISO 10993-1:2009/Cor 1:2010)
• AFNOR NF EN ISO 13485 : Medical devices - Quality management systems - Requirements for regulatory purposes
• DS DS/EN 1041 : Information supplied by the manufacturer of medical devices
• DS DS/EN 980 : Symbols for use in the labelling of medical devices

See More Documents